Research: Brian McGowan
From NHS Greater Glasgow and Clyde yesterday:
Glasgow scientists have been awarded a major cash boost from Cancer Research UK to pioneer new radiotherapy technologies and techniques that could help more people survive cancer in the future.
Experts from the Cancer Research UK Glasgow Centre are set to receive £3.5 million over the next five years.
Glasgow has been chosen to be one of just seven centres of excellence** in a UK-wide network that will accelerate advances in radiotherapy research. Centres will also be located in Manchester, Cambridge, Oxford, Leeds and London.
Cancer Research UK is investing a total of £56 million in Cancer Research UK RadNet – the charity’s largest ever investment in radiotherapy research.
More than 130,000 patients in the UK are treated with radiotherapy on the NHS every year. In its simplest form, the treatment works by targeting tumours with x-ray radiation, killing cancer cells by irreversibly damaging their DNA.
Cancer Research UK supported some of the earliest research into the treatment of cancer with radiation and pioneered the first use of radiotherapy in the 1920s.
In Glasgow, the funding will support researchers to develop and test new radiotherapy-drug combinations and new radiotherapy techniques. Scientists and doctors will focus on improving radiotherapy for patients with hard-to-treat cancers and cancers with poor prognosis, such as lung, brain, pancreatic, and head and neck cancers. And they will carry out research to develop personalised radiotherapy treatment, by developing new imaging techniques and identifying molecular and genetic signatures of cancers that can predict how well each patient will respond to radiotherapy.
Earlier positive news on cancer treatment in Scotland: